* The Company has allotted 4,000 equity shares on June 24, 2026. Applications for the listing of these shares will be submitted to BSE Limited and National Stock Exchange of India Limited. The approval of corporate action is pending as on June 30 2026.
Who is buying / selling · last 12 months (NSE)
Date
Party
Type
Side
Qty
Price
25 May 26
Hdfc Mutual Fund
Block deal
BUY
10,00,000
₹1,225.00
25 May 26
Sunil Sachdeva
Block deal
SELL
10,00,000
₹1,225.00
About the company
From latest AR & concall
Reading the latest annual report and earnings call… (1–3 min on first visit)
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
